Literature DB >> 5150797

Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. I. Variation of the rifampicin serum levels (947 determinations).

L Verbist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5150797     DOI： 10.1159/000194957

Source DB:  PubMed          Journal:  Respiration        ISSN： 0025-7931            Impact factor:   3.580


× No keyword cloud information.
  4 in total

1.  Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.

Authors:  Ian M Rosenthal; Rokeya Tasneen; Charles A Peloquin; Ming Zhang; Deepak Almeida; Khisimuzi E Mdluli; Petros C Karakousis; Jacques H Grosset; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 2.  The chemotherapy of tuberculosis: past, present and future.

Authors:  D Mitchison; G Davies
Journal:  Int J Tuberc Lung Dis       Date:  2012-06       Impact factor: 2.373

3.  Assessment of the Efficacy of New Anti-Tuberculosis Drugs.

Authors:  Denis A Mitchison; Geraint R Davies
Journal:  Open Infect Dis J       Date:  2008-12

4.  Single-dose pharmacokinetics of rifapentine in women.

Authors:  A C Keung; M G Eller; S J Weir
Journal:  J Pharmacokinet Biopharm       Date:  1998-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.